Company profile
Tracon Pharmaceuticals, Inc. Insider Trading
TCONEvery SEC Form 4 insider trading filing for Tracon Pharmaceuticals, Inc. (TCON) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Sector
- Biological Products, (No Diagnostic Substances)
- CIK
- 0001394319
- Filings
- 11
- Insiders
- 10
- Last filing
- 2024-03-12
Activity summary
No insider transactions in the last 30 days. The most recent was on March 12, 2024, when Theuer Charles bought 518,300 shares. 11 filings from 10 insiders are on record below.
Quarterly balance
Buy and sell value by quarter, Q2 23 to Q1 24. Tracon Pharmaceuticals, Inc. insiders are net sellers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $1.4M.
No insider activity recorded for TCON in the last 90 days.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 12, 2024 | Theuer Charles | TCON | Award | 518,300 | — | — |
| Mar 12, 2024 | Brown Scott B. | TCON | Award | 224,800 | — | — |
| Nov 10, 2023 | Opaleye Management Inc. | TCON | Sale | 4,324,008 | $0.29 | $1.27M |
| Nov 10, 2023 | Opaleye Management Inc. | TCON | Sale | 440,000 | $0.29 | $129K |
| Oct 20, 2023 | Theuer Charles | TCON | Award | 3,500 | $0.13 | $467 |
11 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=TCON" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.